GlobeNewsWire
03 Aug 2026, 10:30 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Supernus Pharmaceuticals and Indivior Pharmaceuticals have entered a definitive agreement to combine in an all-stock merger of equals. — Corporate mergers of this scale typically trigger immediate price adjustments to align with the exchange ratio and reflect the creation of a larger, diversified CNS entity.
+0.60Indivior Pharmaceuticals stockholders will receive a one-time special cash dividend of $1.0 billion immediately prior to the merger closing. — A massive cash payout to shareholders is a strong positive catalyst for Indivior's stock value and risk appetite.
+0.50The companies expect to realize $125 million in annual cost synergies from the merger. — Material cost reductions improve future margins and earnings per share, providing a fundamental tailwind for the combined company.
+0.30Continue reading
6 related stories
Top 2 movers · tap to explore
The transaction will be financed in part by a new $650 million debt commitment through a term loan facility from Citibank N.A. — Increased leverage adds financial risk to the balance sheet of the combined entity, which may weigh on valuation.
-0.20Which stocks this story touches
The company is merging to create a diversified CNS leader and its stockholders will receive a one-time special cash dividend of $1.0 billion.
The company is entering a merger of equals expected to generate $125 million in annual cost synergies and drive durable growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Reuters
47m ago
